Shandong Provincial Hospital

Colorectal cancer organoids advance precision medicine by mimicking tumors, aiding research, therapy, and drug development. Integration with single-cell tech enhances insights into tumor heterogeneity and treatment response, driving personalized approaches. Challenges and future potential in standardization, high-throughput screening, and multi-omics integration are discussed.